Release Date: 30/04/13 10:07 Summary: CFCL Funding Update Price Sensitive: Yes Download Document 31.9KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%